Bromodomain and Extra Terminal Domain (BET) Inhibitors Sensitize Chronic Myelomonocytic Leukemia (CMML) to PIM Inhibition Via Downregulation of Mir-33a
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Christopher Letson, Alexis Vedder, Ariel Quintana, Phillip Liu, Brett Reid, Maria E Balasis, Hannah Newman, Traci Kruer, Luciana L Almada, Guolin Zhang, Martin Fernandez-Zapico, Mrinal M Patnaik, Jeffrey E. Lancet, Rami S. Komrokji, P.K. Epling-Burnette, Alan F. List, Eric B. Haura, Gary W. Reuther, Thomas A. Sellers, Holly K. Koblish, Eric Padron
Institutions: Moffitt Cancer Center, Incyte (United States), Mayo Clinic
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2983443228